Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04568148 · ClinicalTrials.gov registry record
COVID-19 Biorepository
A clinical trial of COVID-19 and SARS-CoV-2, sponsored by University of Kansas Medical Center.
- Active
- Registry status
- 201
- Enrollment target
- 1
- Study location
NCT04568148: Active study of COVID-19 and SARS-CoV-2, sponsored by University of Kansas Medical Center.
NCT04568148 is a study of COVID-19 and SARS-CoV-2 that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 201 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04568148, a study of COVID-19 and SARS-CoV-2, is active but no longer recruiting, sponsored by University of Kansas Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 201 participants
- Enrollment target
- 1
- Study location
Study Summary
Establish a COVID-19 biorepository to aid in developing our knowledge of the disease.
Primary Outcome
Establish a collection of biospecimens from patients with COVID-19.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT04568148 still lists
NCT04568148 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04568148 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT04568148 about?
NCT04568148 is a clinical study titled "COVID-19 Biorepository". Establish a COVID-19 biorepository to aid in developing our knowledge of the disease.
What is the current status of trial NCT04568148?
This trial is currently active not recruiting. The enrollment target is 201 participants. The study started on 2020-04-15. Estimated completion is 2025-12-31.
What conditions does trial NCT04568148 study?
This clinical trial studies the following conditions: COVID-19, SARS-CoV-2, Coronavirus, COVID.
Who is sponsoring clinical trial NCT04568148?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04568148 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04568148's enrollment target sits among peer trials
201 159th of 298 higher than 139 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI